-
Founded in:
2002-02-10 -
Country:
China -
Address:
No. 8 Changxing Road, Gaoyou City -
Tax NO.:
913210846087092887 -
Registered Funds:
$6.25 million -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ibuprofen |
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects. |
20mg | 15687-27-1 | 54 |
| Starch |
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects. |
9005-25-8 | 77 | |
| Xanthan gum |
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects. |
11138-66-2 | 5 | |
| Glycerol |
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects. |
56-81-5 | 61 | |
| Sucrose |
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects. |
57-50-1 | 71 | |
| Anhydrous magnesium citrate |
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects. |
0 | ||
| Sodium benzoate |
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects. |
532-32-1 | 23 | |
| Tween 80 |
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects. |
9005-65-6 | 17 | |
| Food pigment |
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects. |
0 | ||
| Edible essence |
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects. |
0 | ||
| Pure water |
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects.
More
This product can inhibit the synthesis of prostaglandins and has antipyretic, analgesic and anti-inflammatory effects. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Dihydroergotoxine mesylate |
It changes the brain's neurotransmission, has an agonist effect on dopamine and 5-hydroxytryptamine receptors, a blocking effect on α-adrenaline receptors, improves damaged brain metabolic function, and shortens cerebral circulation time. This effect is reflected in changes in the brain's electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG).
More
It changes the brain's neurotransmission, has an agonist effect on dopamine and 5-hydroxytryptamine receptors, a blocking effect on α-adrenaline receptors, improves damaged brain metabolic function, and shortens cerebral circulation time. This effect is reflected in changes in the brain's electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG). |
8067-24-1 | 12 | |
| Dihydroergodine mesylate |
Animal experiments have shown that dihydroergoline mesylate changes brain neurotransmission, and data show that it has an agonist effect on dopamine and 5-hydroxytryptamine receptors and a blocker effect on α-adrenaline receptors. It improves damaged brain metabolic function and shortens brain circulation time. This effect is reflected in changes in brain electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG).
More
Animal experiments have shown that dihydroergoline mesylate changes brain neurotransmission, and data show that it has an agonist effect on dopamine and 5-hydroxytryptamine receptors and a blocker effect on α-adrenaline receptors. It improves damaged brain metabolic function and shortens brain circulation time. This effect is reflected in changes in brain electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG). |
0 | ||
| Dihydroergocrine mesylate |
Animal experiments have shown that dihydroergoline mesylate changes brain neurotransmission, and data show that it has an agonist effect on dopamine and 5-hydroxytryptamine receptors and a blocker effect on α-adrenaline receptors. It improves damaged brain metabolic function and shortens brain circulation time. This effect is reflected in changes in brain electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG).
More
Animal experiments have shown that dihydroergoline mesylate changes brain neurotransmission, and data show that it has an agonist effect on dopamine and 5-hydroxytryptamine receptors and a blocker effect on α-adrenaline receptors. It improves damaged brain metabolic function and shortens brain circulation time. This effect is reflected in changes in brain electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG). |
0 | ||
| Dihydroergodine mesylate |
Animal experiments have shown that dihydroergoline mesylate changes brain neurotransmission, and data show that it has an agonist effect on dopamine and 5-hydroxytryptamine receptors and a blocker effect on α-adrenaline receptors. It improves damaged brain metabolic function and shortens brain circulation time. This effect is reflected in changes in brain electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG).
More
Animal experiments have shown that dihydroergoline mesylate changes brain neurotransmission, and data show that it has an agonist effect on dopamine and 5-hydroxytryptamine receptors and a blocker effect on α-adrenaline receptors. It improves damaged brain metabolic function and shortens brain circulation time. This effect is reflected in changes in brain electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG). |
0 | ||
| Dihydro-α-ergocine mesylate |
Animal experiments have shown that dihydroergoline mesylate changes brain neurotransmission, and data show that it has an agonist effect on dopamine and 5-hydroxytryptamine receptors and a blocker effect on α-adrenaline receptors. It improves damaged brain metabolic function and shortens brain circulation time. This effect is reflected in changes in brain electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG).
More
Animal experiments have shown that dihydroergoline mesylate changes brain neurotransmission, and data show that it has an agonist effect on dopamine and 5-hydroxytryptamine receptors and a blocker effect on α-adrenaline receptors. It improves damaged brain metabolic function and shortens brain circulation time. This effect is reflected in changes in brain electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG). |
0 | ||
| Dihydro-β-ergocine mesylate |
Animal experiments have shown that dihydroergoline mesylate changes brain neurotransmission, and data show that it has an agonist effect on dopamine and 5-hydroxytryptamine receptors and a blocker effect on α-adrenaline receptors. It improves damaged brain metabolic function and shortens brain circulation time. This effect is reflected in changes in brain electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG).
More
Animal experiments have shown that dihydroergoline mesylate changes brain neurotransmission, and data show that it has an agonist effect on dopamine and 5-hydroxytryptamine receptors and a blocker effect on α-adrenaline receptors. It improves damaged brain metabolic function and shortens brain circulation time. This effect is reflected in changes in brain electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG). |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pancreatin |
It contains amylase, protease and lipase, which can be used to improve the digestion and absorption of carbohydrates, fats and proteins, and restore the body's normal digestive function.
More
It contains amylase, protease and lipase, which can be used to improve the digestion and absorption of carbohydrates, fats and proteins, and restore the body's normal digestive function. |
100mg | 8049-47-6 | 27 |
| azintamide |
A bile secretion promoting drug that increases the amount of fluid in bile and increases the secretion of solid components in bile.
More
A bile secretion promoting drug that increases the amount of fluid in bile and increases the secretion of solid components in bile. |
75mg | 1830-32-6 | 4 |
| Dimethicone |
It has the effect of reducing gas, which can reduce the gas in the gastrointestinal tract to a minimum, thereby eliminating stomach pain caused by bloating in the gastrointestinal tract, and can also eliminate bloating caused by other organs in the digestive tract.
More
It has the effect of reducing gas, which can reduce the gas in the gastrointestinal tract to a minimum, thereby eliminating stomach pain caused by bloating in the gastrointestinal tract, and can also eliminate bloating caused by other organs in the digestive tract. |
50mg | 9006-65-9 | 21 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Terazosin hydrochloride |
This product is a selective α1 receptor blocker that can reduce peripheral vascular resistance and has a lowering effect on both systolic and diastolic blood pressure; it has the effect of relaxing bladder and prostate smooth muscles and can relieve symptoms of dysuria caused by benign prostatic hypertrophy.
More
This product is a selective α1 receptor blocker that can reduce peripheral vascular resistance and has a lowering effect on both systolic and diastolic blood pressure; it has the effect of relaxing bladder and prostate smooth muscles and can relieve symptoms of dysuria caused by benign prostatic hypertrophy. |
63074-08-8 | 18 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| DL-Lysine acetylsalicylate |
This product is a complex salt of aspirin and lysine, which can inhibit cyclooxygenase, reduce the synthesis of prostaglandins, and has antipyretic, analgesic and anti-inflammatory effects.
More
This product is a complex salt of aspirin and lysine, which can inhibit cyclooxygenase, reduce the synthesis of prostaglandins, and has antipyretic, analgesic and anti-inflammatory effects. |
62952-06-1 | 13 |